<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03655860</url>
  </required_header>
  <id_info>
    <org_study_id>SIMEOX-01</org_study_id>
    <secondary_id>2018/08AOU/312</secondary_id>
    <nct_id>NCT03655860</nct_id>
  </id_info>
  <brief_title>Effects of SIMEOX on Flow and Volume</brief_title>
  <official_title>Evaluation of SIMEOX on Flow and Volume Elicited in Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will investigate the effects of the SIMEOX (an airway clearance device) on flow
      and volume generated in healthy subjects
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a pilot study assessing the effect of the SIMEOX device on flow and volume generated
      in healthy subjects.

      Assessment of flow and volume will be performed before and during the application of the
      SIMEOX. Vital capacity and expiratory flow will be assessed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 15, 2018</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in expiratory volume</measure>
    <time_frame>5min</time_frame>
    <description>Expiratory volume before and during the use of the SIMEOX will be compared</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in expiratory volume flow rate</measure>
    <time_frame>5min</time_frame>
    <description>Expiratory flow rate before and during the use of the SIMEOX will be compared</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>SIMEOX</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SIMEOX</intervention_name>
    <description>SIMEOX is a device generating a succession of gentle depression at the mouth.</description>
    <arm_group_label>SIMEOX</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Able to understand the instructions

        Exclusion Criteria:

          -  Obesity (BMI &gt; 30kg/m²)

          -  Active smoker

          -  Severe scoliosis

          -  Cardiovascular ou neuromuscular disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>William Poncin</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Poncin, PT, PhD</last_name>
      <phone>+327642718</phone>
      <email>william.poncin@uclouvain.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>August 28, 2018</study_first_submitted>
  <study_first_submitted_qc>August 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2018</study_first_posted>
  <last_update_submitted>March 8, 2019</last_update_submitted>
  <last_update_submitted_qc>March 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

